| 201 | Jiangxi Fushine Pharmaceutical Co., Ltd. | 300497.SZ | SHZ | CN |
| 202 | Maze Therapeutics, Inc. | MAZE | NASDAQ | US |
| 203 | Tibet Cheezheng Tibetan Medicine Co., Ltd. | 002287.SZ | SHZ | CN |
| 204 | Staidson (Beijing) BioPharmaceuticals Co., Ltd. | 300204.SZ | SHZ | CN |
| 205 | Recursion Pharmaceuticals, Inc. | RXRX | NASDAQ | US |
| 206 | Aktis Oncology, Inc. | AKTS | NASDAQ | US |
| 207 | Precigen, Inc. | PGEN | NASDAQ | US |
| 208 | Vir Biotechnology, Inc. | VIR | NASDAQ | US |
| 209 | Ascentage Pharma Group International | ASPHF | OTC | CN |
| 210 | Biohaven Ltd. | BHVN | NYSE | US |
| 211 | Beijing Hotgen Biotech Co., Ltd. | 688068.SS | SHH | CN |
| 212 | Maravai LifeSciences Holdings, Inc. | MRVI | NASDAQ | US |
| 213 | Innoviva, Inc. | INVA | NASDAQ | US |
| 214 | Fortrea Holdings Inc. | FTRE | NASDAQ | US |
| 215 | Taysha Gene Therapies, Inc. | TSHA | NASDAQ | US |
| 216 | ArriVent BioPharma, Inc. | AVBP | NASDAQ | US |
| 217 | Mabwell-b | 2493.HK | HKSE | CN |
| 218 | Novavax, Inc. | NVAX | NASDAQ | US |
| 219 | Oxford Nanopore Technologies plc | ONTTF | OTC | GB |
| 220 | Bicara Therapeutics Inc. Common Stock | BCAX | NASDAQ | US |
| 221 | Chengzhi Shareholding Co., Ltd. | 000990.SZ | SHZ | CN |
| 222 | Pharma Mar, S.A. | PHM.MC | BME | ES |
| 223 | Monte Rosa Therapeutics, Inc. | GLUE | NASDAQ | US |
| 224 | Ascletis Pharma Inc. | 1672.HK | HKSE | CN |
| 225 | Iovance Biotherapeutics, Inc. | IOVA | NASDAQ | US |
| 226 | Septerna Inc | SEPN | NASDAQ | US |
| 227 | Amylyx Pharmaceuticals, Inc. | AMLX | NASDAQ | US |
| 228 | Hualan Biological Bacterin Inc. | 301207.SZ | SHZ | CN |
| 229 | Chengdu Easton Biopharmaceuticals Co., Ltd. | 688513.SS | SHH | CN |
| 230 | Neuren Pharmaceuticals Limited | NEU.AX | ASX | AU |
| 231 | Zhejiang Jolly Pharmaceutical Co.,LTD | 300181.SZ | SHZ | CN |
| 232 | Inhibrx Biosciences Inc. | INBX | NASDAQ | US |
| 233 | Xeris Biopharma Holdings, Inc. | XERS | NASDAQ | US |
| 234 | CanSino Biologics Inc. | 688185.SS | SHH | CN |
| 235 | Rapport Therapeutics, Inc. Common Stock | RAPP | NASDAQ | US |
| 236 | Ascletis Pharma Inc. | ASCLF | OTC | CN |
| 237 | Nanjing Vazyme Biotech Co., Ltd. | 688105.SS | SHH | CN |
| 238 | MannKind Corporation | MNKD | NASDAQ | US |
| 239 | MoonLake Immunotherapeutics | MLTX | NASDAQ | CH |
| 240 | Nektar Therapeutics | NKTR | NASDAQ | US |
| 241 | Concord Biotech Limited | CONCORDBIO.NS | NSE | IN |
| 242 | Porton Pharma Solutions Ltd. | 300363.SZ | SHZ | CN |
| 243 | Tennor Therap-b | 6872.HK | HKSE | CN |
| 244 | Immatics N.V. | IMTX | NASDAQ | DE |
| 245 | HBM Holdings Limited | HBMHF | OTC | CN |
| 246 | Ardelyx, Inc. | ARDX | NASDAQ | US |
| 247 | MeiraGTx Holdings plc | MGTX | NASDAQ | US |
| 248 | Corvus Pharmaceuticals, Inc. | CRVS | NASDAQ | US |
| 249 | Savara Inc. | SVRA | NASDAQ | US |
| 250 | Nanjing Leads Biolabs Co Ltd | 9887.HK | HKSE | CN |
| 251 | Everest Medicines Limited | 1952.HK | HKSE | CN |
| 252 | Vcanbio Cell & Gene Engineering Corp., Ltd | 600645.SS | SHH | CN |
| 253 | HBM Holdings Limited | 2142.HK | HKSE | CN |
| 254 | Lin BioScience, Inc. | 6696.TWO | TWO | TW |
| 255 | Zenas BioPharma, Inc. | ZBIO | NASDAQ | US |
| 256 | MedinCell S.A. | MEDCL.PA | PAR | FR |
| 257 | ORIC Pharmaceuticals, Inc. | ORIC | NASDAQ | US |
| 258 | Wave Life Sciences Ltd. | WVE | NASDAQ | SG |
| 259 | EyePoint Pharmaceuticals, Inc. | EYPT | NASDAQ | US |
| 260 | CARsgen Therapeutics Holdings Limited | 2171.HK | HKSE | CN |
| 261 | OPKO Health, Inc. | OPK | NASDAQ | US |
| 262 | Seaport Therapeutics, Inc. Common Stock | SPTX | NASDAQ | US |
| 263 | Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 600866.SS | SHH | CN |
| 264 | Guilin Sanjin Pharmaceutical Co., Ltd. | 002275.SZ | SHZ | CN |
| 265 | China Resources Boya Bio-pharmaceutical Group Co., Ltd. | 300294.SZ | SHZ | CN |
| 266 | Sana Biotechnology, Inc. | SANA | NASDAQ | US |
| 267 | Xencor, Inc. | XNCR | NASDAQ | US |
| 268 | CStone Pharmaceuticals | 2616.HK | HKSE | CN |
| 269 | Olema Pharmaceuticals, Inc. | OLMA | NASDAQ | US |
| 270 | CanSino Biologics Inc. | 6185.HK | HKSE | HK |
| 271 | Daan Gene Co., Ltd. | 002030.SZ | SHZ | CN |
| 272 | Capricor Therapeutics, Inc. | CAPR | NASDAQ | US |
| 273 | Abbisko Cayman Limited | 2256.HK | HKSE | CN |
| 274 | Zhejiang Ausun Pharmaceutical Co., Ltd. | 603229.SS | SHH | CN |
| 275 | Lexicon Pharmaceuticals, Inc. | LXRX | NASDAQ | US |
| 276 | Lepu Biopharma Co., Ltd. | 2157.HK | HKSE | CN |
| 277 | Blue Jet Healthcare Limited | BLUEJET.NS | NSE | IN |
| 278 | Janux Therapeutics, Inc. | JANX | NASDAQ | US |
| 279 | Youcare Pharmaceutical Group Co., Ltd. | 688658.SS | SHH | CN |
| 280 | Pharming Group N.V. | PHARM.AS | AMS | NL |
| 281 | Kura Oncology, Inc. | KURA | NASDAQ | US |
| 282 | GNI Group Ltd. | 2160.T | JPX | JP |
| 283 | Design Therapeutics, Inc. | DSGN | NASDAQ | US |
| 284 | Replimune Group, Inc. | REPL | NASDAQ | US |
| 285 | Arbutus Biopharma Corp | ABUS | NASDAQ | US |
| 286 | LB Pharmaceuticals Inc Common Stock | LBRX | NASDAQ | US |
| 287 | CStone Pharmaceuticals | CSPHF | OTC | CN |
| 288 | BioAge Labs Inc. | BIOA | NASDAQ | US |
| 289 | Alphamab Oncology | 9966.HK | HKSE | CN |
| 290 | Kuros Biosciences AG | KURN.SW | SIX | CH |
| 291 | Chengdu Kanghua Biological Products Co., Ltd. | 300841.SZ | SHZ | CN |
| 292 | Xiangxue Pharmaceutical Co.,Ltd. | 300147.SZ | SHZ | CN |
| 293 | Wuhan Keqian Biology Co.,Ltd | 688526.SS | SHH | CN |
| 294 | Phathom Pharmaceuticals, Inc. | PHAT | NASDAQ | US |
| 295 | Jiangsu Aidea Pharmaceutical Co., Ltd. | 688488.SS | SHH | CN |
| 296 | Climb Bio, Inc. | CLYM | NASDAQ | US |
| 297 | Theravance Biopharma Inc | TBPH | NASDAQ | US |
| 298 | Shanghai Haohai Biological Technology Co., Ltd. | 688366.SS | SHH | CN |
| 299 | Alto Neuroscience, Inc. | ANRO | NYSE | US |
| 300 | Oneness Biotech Co., Ltd. | 4743.TWO | TWO | TW |
| 301 | CHO Pharma, Inc. | 6586.TWO | TWO | TW |
| 302 | ARS Pharmaceuticals, Inc. | SPRY | NASDAQ | US |
| 303 | Geron Corporation | GERN | NASDAQ | US |
| 304 | Solid Biosciences Inc. | SLDB | NASDAQ | US |
| 305 | Basilea Pharmaceutica AG | BSLN.SW | SIX | CH |
| 306 | Zhejiang Wecome Pharmaceutical Company Limited | 300878.SZ | SHZ | CN |
| 307 | Zevra Therapeutics, Inc. | ZVRA | NASDAQ | US |
| 308 | Gubra A/S | GUBRA.CO | CPH | DK |
| 309 | Novogene Co., Ltd. | 688315.SS | SHH | CN |
| 310 | Philogen S.p.A. | PHIL.MI | MIL | IT |
| 311 | Hangzhou Biotest Biotech Co.,Ltd. | 688767.SS | SHH | CN |
| 312 | PeptiDream Inc. | 4587.T | JPX | JP |
| 313 | Oculis Holding AG | OCS | NASDAQ | CH |
| 314 | GuiZhou SanLi Pharmaceutical Co.,Ltd | 603439.SS | SHH | CN |
| 315 | Hunan Jiudian Pharmaceutical Co., Ltd. | 300705.SZ | SHZ | CN |
| 316 | Beijing Konruns Pharmaceutical Co.,Ltd. | 603590.SS | SHH | CN |
| 317 | Genfit S.A. | GNFT.PA | PAR | FR |
| 318 | Hvsen Biotechnology Co., Ltd. | 300871.SZ | SHZ | CN |
| 319 | Rigel Pharmaceuticals, Inc. | RIGL | NASDAQ | US |
| 320 | Tectonic Therapeutic, Inc. | TECX | NASDAQ | US |
| 321 | SpyGlass Pharma, Inc. Common Stock | SGP | NASDAQ | US |
| 322 | Orum Therapeutics, Inc. | 475830.KQ | KOE | KR |
| 323 | Jade Biosciences, Inc. | JBIO | NASDAQ | US |
| 324 | Prime Medicine, Inc. | PRME | NASDAQ | US |
| 325 | REGENXBIO Inc. | RGNX | NASDAQ | US |
| 326 | CorMedix Inc. | CRMD | NASDAQ | US |
| 327 | ProKidney Corp. | PROK | NASDAQ | US |
| 328 | 4D Molecular Therapeutics, Inc. | FDMT | NASDAQ | US |
| 329 | Omeros Corporation | OMER | NASDAQ | US |
| 330 | Gyre Therapeutics, Inc. | GYRE | NASDAQ | US |
| 331 | Aclaris Therapeutics, Inc. | ACRS | NASDAQ | US |
| 332 | Esperion Therapeutics, Inc. | ESPR | NASDAQ | US |
| 333 | Relmada Therapeutics, Inc. | RLMD | NASDAQ | US |
| 334 | Achieve Life Sciences, Inc. | ACHV | NASDAQ | CA |
| 335 | Monopar Therapeutics Inc. | MNPR | NASDAQ | US |
| 336 | Annexon, Inc. | ANNX | NASDAQ | US |
| 337 | BridgeBio Oncology Therapeutics Inc. | BBOT | NASDAQ | US |
| 338 | Kexing Biopharm Co., Ltd. | 688136.SS | SHH | CN |
| 339 | Sunmax Biotechnology Co., Ltd. | 4728.TWO | TWO | TW |
| 340 | PYC Therapeutics Limited | PYC.AX | ASX | AU |
| 341 | AgomAb Therapeutics N.V. American Depositary Shares | AGMB | NASDAQ | BE |
| 342 | Anhui Huaheng Biotechnology Co., Ltd. | 688639.SS | SHH | CN |
| 343 | CytomX Therapeutics, Inc. | CTMX | NASDAQ | US |
| 344 | Lifecome Biochemistry Co.,Ltd. | 002868.SZ | SHZ | CN |
| 345 | Shanghai Shen Lian Biomedical Corporation | 688098.SS | SHH | CN |
| 346 | Beijing Scitop Bio-tech Co., Ltd. | 300858.SZ | SHZ | CN |
| 347 | Jiangsu Bioperfectus Technologies Co., Ltd. | 688399.SS | SHH | CN |
| 348 | TaiMed Biologics Inc. | 4147.TWO | TWO | TW |
| 349 | MiMedx Group, Inc. | MDXG | NASDAQ | US |
| 350 | Contineum Therapeutics, Inc. | CTNM | NASDAQ | US |
| 351 | Immix Biopharma, Inc. | IMMX | NASDAQ | US |
| 352 | Lumosa Therapeutics Co., Ltd. | 6535.TWO | TWO | TW |
| 353 | First Tracks Biotherapeutics Inc | TRAX | NASDAQ | US |
| 354 | DBV Technologies S.A. | DBV.PA | PAR | FR |
| 355 | Neurogene Inc. | NGNE | NASDAQ | US |
| 356 | Nxera Pharma Co., Ltd. | 4565.T | JPX | JP |
| 357 | Odyssey Therapeutics, Inc. | ODTX | NASDAQ | US |
| 358 | Inventiva S.A. | IVA.PA | PAR | FR |
| 359 | Arvinas, Inc. | ARVN | NASDAQ | US |
| 360 | Candel Therapeutics, Inc. | CADL | NASDAQ | US |
| 361 | XOMA Royalty Corp. | XOMA | NASDAQ | US |
| 362 | Chabiotech Co.,Ltd. | 085660.KQ | KOE | KR |
| 363 | Hubei Goto Biopharm Co.,Ltd. | 300966.SZ | SHZ | CN |
| 364 | Pulike Biological Engineering, Inc. | 603566.SS | SHH | CN |
| 365 | Bright Minds Biosciences Inc. | DRUG.CN | CNQ | CA |
| 366 | Jiangsu Sihuan Bioengineering Co., Ltd | 000518.SZ | SHZ | CN |
| 367 | Ocumension Therapeutics | 1477.HK | HKSE | CN |
| 368 | Cabaletta Bio, Inc. | CABA | NASDAQ | US |
| 369 | Jacobio Pharmaceuticals Group Co., Ltd. | 1167.HK | HKSE | CN |
| 370 | Nuvectis Pharma, Inc. | NVCT | NASDAQ | US |
| 371 | SanBio Company Limited | 4592.T | JPX | JP |
| 372 | Ocugen, Inc. | OCGN | NASDAQ | US |
| 373 | Prothena Corporation plc | PRTA | NASDAQ | IE |
| 374 | Allogene Therapeutics, Inc. | ALLO | NASDAQ | US |
| 375 | Valneva SE | VLA.PA | PAR | FR |
| 376 | Ever Supreme Bio Technology Co., Ltd | 6712.TWO | TWO | TW |
| 377 | Pharmicell Co., Ltd. | 005690.KS | KSC | KR |
| 378 | Aura Biosciences, Inc. | AURA | NASDAQ | US |
| 379 | Baolingbao Biology Co.,Ltd. | 002286.SZ | SHZ | CN |
| 380 | Guanhao Biotech Co.,Ltd. | 300238.SZ | SHZ | CN |
| 381 | Medigen Vaccine Biologics Corp. | 6547.TWO | TWO | TW |
| 382 | Rezolute, Inc. | RZLT | NASDAQ | US |
| 383 | Crescent Biopharma, Inc. | CBIO | NASDAQ | US |
| 384 | Guangzhou Innogen Pharmaceutl Grp Co Ltd | 2591.HK | HKSE | CN |
| 385 | Avacta Group Plc | AVCTF | OTC | GB |
| 386 | EirGenix Inc. | 6589.TWO | TWO | TW |
| 387 | Qingdao Vland Biotech Inc. | 603739.SS | SHH | CN |
| 388 | TransThera Sciences (Nanjing). Inc. | 2617.HK | HKSE | CN |
| 389 | Hefei Lifeon Pharmaceutical Co., Ltd. | 003020.SZ | SHZ | CN |
| 390 | Zota Health Care Limited | ZOTA.NS | NSE | IN |
| 391 | Shanghai ZJ Bio-Tech Co., Ltd. | 688317.SS | SHH | CN |
| 392 | Assembly Biosciences, Inc. | ASMB | NASDAQ | US |
| 393 | Qyuns Therapeutics Co., Ltd. | 2509.HK | HKSE | CN |
| 394 | Beijing Kawin Technology Share-Holding Co., Ltd. | 688687.SS | SHH | CN |
| 395 | Emergent BioSolutions Inc. | EBS | NYSE | US |
| 396 | Puma Biotechnology, Inc. | PBYI | NASDAQ | US |
| 397 | Guangdong VTR Bio-Tech Co., Ltd. | 300381.SZ | SHZ | CN |
| 398 | Shanghai Model Organisms Center, Inc. | 688265.SS | SHH | CN |
| 399 | Rocket Pharmaceuticals, Inc. | RCKT | NASDAQ | US |
| 400 | Berry Genomics Co.,Ltd | 000710.SZ | SHZ | CN |
Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
